Radiation Dose-escalated Chemoradiotherapy Using Simultaneous Integrated Boost Intensity-Modulated Radiotherapy for Locally Advanced Unresectable Thoracic Oesophageal Squamous Cell Carcinoma: A Single-institution Phase I Study

Oesophageal Squamous Cell Carcinoma ◽

Single Institution ◽

Intensity Modulated ◽

Integrated Boost

Radiation Dose Escalated Chemoradiotherapy Using Simultaneous Integrated Boost Intensity-Modulated Radiotherapy for Locally Advanced Unresectable Thoracic Esophageal Squamous Cell Carcinoma: A Single Institutional Phase I Study

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2019.06.2018 ◽

2019 ◽

Vol 105 (1) ◽

pp. E196-E197

Author(s):

K. Sakanaka ◽

Y. Ishida ◽

K. Fujii ◽

Y. Ishihara ◽

M. Nakamura ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Radiation Dose ◽

Esophageal Squamous Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Phase I Study ◽

Locally Advanced ◽

Intensity Modulated ◽

Integrated Boost

P-68 Concurrent Weekly Cisplatin and Simultaneous Integrated Boost-Intensity Modulated Radiotherapy (SIB-IMRT) in Locally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)

Oral Oncology ◽

10.1016/s1368-8375(21)00355-9 ◽

2021 ◽

Vol 118 ◽

pp. 15

Author(s):

Imtiaz Ahmed ◽

Sapna Krishnamurthy ◽

Rohan Bhise ◽

Kumar Vinchurkar ◽

Mahesh Kalloli

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Locally Advanced ◽

Advanced Head ◽

Intensity Modulated ◽

Integrated Boost ◽

Weekly Cisplatin

Intensity-modulated radiotherapy using simultaneous-integrated boost for definitive treatment of locally advanced mucosal head and neck cancer: Outcomes from a single-institution series

Journal of Medical Imaging and Radiation Oncology ◽

10.1111/1754-9485.12033 ◽

2013 ◽

Vol 57 (3) ◽

pp. 356-363 ◽

Cited By ~ 7

Author(s):

Meredith Johnston ◽

Linxin Guo ◽

Michael Back ◽

Alex Guminski ◽

Adrian Lee ◽

...

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Neck Cancer ◽

Locally Advanced ◽

Definitive Treatment ◽

Cancer Outcomes ◽

Single Institution ◽

Intensity Modulated ◽

Integrated Boost

Phase I trial of cetuximab, intensity modulated radiotherapy (IMRT), and ipilimumab in previously untreated, locally advanced head and neck squamous cell carcinoma (PULA HNSCC)

Annals of Oncology ◽

10.1093/annonc/mdx374.014 ◽

2017 ◽

Vol 28 ◽

pp. v379 ◽

Cited By ~ 1

Author(s):

R.L. Ferris ◽

D.A. Clump ◽

J. Ohr ◽

W. Gooding ◽

S. Kim ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Phase I Trial ◽

Locally Advanced ◽

Advanced Head ◽

Outcomes of Primary Concurrent Chemotherapy and Intensity Modulated Radiotherapy for Locally Advanced Laryngeal Squamous cell Carcinoma: Focus on T3 Larynx - a European Single Institution Analysis

10.22541/au.159366961.16866254 ◽

2020 ◽

Author(s):

Delali Adjogatse ◽

Francesca De Felice ◽

Yae Eun Suh ◽

Enyi Ofo ◽

Jean Pierre Jeannon ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Laryngeal Squamous Cell Carcinoma ◽

Locally Advanced ◽

Concurrent Chemotherapy ◽

Single Institution ◽

A phase I study of the CDK4/6 inhibitor, palbociclib in combination with cetuximab and intensity modulated radiation therapy (IMRT) for locally advanced squamous cell carcinoma of the head and neck (SCCHN); A result of dose escalation cohort

Annals of Oncology ◽

10.1093/annonc/mdz252.015 ◽

2019 ◽

Vol 30 ◽

pp. v456

Author(s):

N. Ngamphaiboon ◽

C. Jiarpinitnun ◽

T. Siripoon ◽

S. Lukerak ◽

A. Jinawath ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Radiation Therapy ◽

Phase I ◽

Cell Carcinoma ◽

Dose Escalation ◽

Phase I Study ◽

Locally Advanced ◽

Intensity Modulated Radiation Therapy ◽

Advanced Squamous Cell Carcinoma ◽

A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer

Radiotherapy and Oncology ◽

10.1016/j.radonc.2007.07.011 ◽

2007 ◽

Vol 85 (1) ◽

pp. 36-41 ◽

Cited By ~ 37

Author(s):

Teresa Guerrero Urbano ◽

Catharine H. Clark ◽

Vibeke N. Hansen ◽

Elizabeth J. Adams ◽

Roger A’Hern ◽

...

Keyword(s):

Head And Neck Cancer ◽

Phase I ◽

Head And Neck ◽

Neck Cancer ◽

Phase I Study ◽

Locally Advanced ◽

Advanced Head ◽

Intensity-modulated Radiotherapy Allows Escalation of the Radiation Dose to the Pelvic Lymph Nodes in Patients with Locally Advanced Prostate Cancer: Preliminary Results of a Phase I Dose Escalation Study

Clinical Oncology ◽

10.1016/j.clon.2010.01.005 ◽

2010 ◽

Vol 22 (3) ◽

pp. 236-244 ◽

Cited By ~ 26

Author(s):

T. Guerrero Urbano ◽

V. Khoo ◽

J. Staffurth ◽

A. Norman ◽

F. Buffa ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Dose ◽

Phase I ◽

Dose Escalation ◽

Advanced Prostate Cancer ◽

Locally Advanced ◽

Locally Advanced Prostate Cancer ◽

Dose Escalation Study ◽

Phase I study of concurrent selective lymph node late-course accelerated hyperfractionated radiotherapy and S-1 plus cisplatin for locally advanced oesophageal squamous cell carcinoma

British Journal of Radiology ◽

10.1259/bjr.20150476 ◽

2016 ◽

Vol 89 (1060) ◽

pp. 20150476 ◽

Cited By ~ 3

Author(s):

Miaomiao Li ◽

Chengrui Fu ◽

Wei Zhang ◽

Wei Huang ◽

Zhongtang Wang ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Lymph Node ◽

Phase I ◽

Cell Carcinoma ◽

Squamous Cell ◽

Phase I Study ◽

Locally Advanced ◽

Oesophageal Squamous Cell Carcinoma ◽

Hyperfractionated Radiotherapy

Phase I trial of cetuximab, intensity modulated radiotherapy (IMRT), and the anti-CTLA-4 monoclonal antibody (mAb) ipilimumab in previously untreated, locally advanced head and neck squamous cell carcinoma (PULA HNSCC).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.tps6104 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. TPS6104-TPS6104 ◽

Cited By ~ 1

Author(s):

Julie E. Bauman ◽

William E. Gooding ◽

David Andrew Clump ◽

Seungwon Kim ◽

Brian J Karlovits ◽

...

Keyword(s):

Monoclonal Antibody ◽

Squamous Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase I Trial ◽

Locally Advanced ◽

Advanced Head ◽